BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37022947)

  • 21. New perspectives for mitotane treatment of adrenocortical carcinoma.
    Puglisi S; Calabrese A; Basile V; Pia A; Reimondo G; Perotti P; Terzolo M
    Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101415. PubMed ID: 32179008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of adrenocortical carcinoma in adrenal tumours greater than 8 cm.
    Abdel-Aziz TE; Rajeev P; Sadler G; Weaver A; Mihai R
    World J Surg; 2015 May; 39(5):1268-73. PubMed ID: 25526921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane.
    Grubbs EG; Callender GG; Xing Y; Perrier ND; Evans DB; Phan AT; Lee JE
    Ann Surg Oncol; 2010 Jan; 17(1):263-70. PubMed ID: 19851811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma.
    Kim Y; Margonis GA; Prescott JD; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem AI; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
    JAMA Surg; 2016 Apr; 151(4):365-73. PubMed ID: 26676603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical utility of 'GRAS' parameters in stage I-III adrenocortical carcinomas: long-term data from a high-volume institution.
    Liang J; Liu Z; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Wei X; Lu Y; Zhu Y
    Endocrine; 2020 Feb; 67(2):449-456. PubMed ID: 31786772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update in adrenocortical carcinoma.
    Fassnacht M; Kroiss M; Allolio B
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4551-64. PubMed ID: 24081734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study.
    Kimpel O; Bedrose S; Megerle F; Berruti A; Terzolo M; Kroiss M; Mai K; Dekkers OM; Habra MA; Fassnacht M
    Br J Cancer; 2021 Oct; 125(9):1233-1238. PubMed ID: 34400803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of mitotane in the treatment of adrenocortical carcinoma: A retrospective study in 34 Belgian patients.
    Maiter D; Bex M; Vroonen L; T'Sjoen G; Gil T; Banh C; Chadarevian R
    Ann Endocrinol (Paris); 2016 Oct; 77(5):578-585. PubMed ID: 27063476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcutaneous biopsy of adrenocortical carcinoma is rarely helpful in diagnosis, potentially harmful, but does not affect patient outcome.
    Williams AR; Hammer GD; Else T
    Eur J Endocrinol; 2014 Jun; 170(6):829-35. PubMed ID: 24836548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adrenocortical carcinoma.
    Baudin E;
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):411-34. PubMed ID: 26038209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bilateral primary adrenal non-Hodgkin's lymphoma and primary adrenocortical carcinoma--review of the literature preoperative differentiation of adrenal tumors.
    Ozimek A; Diebold J; Linke R; Heyn J; Hallfeldt K; Mussack T
    Endocr J; 2008 Aug; 55(4):625-38. PubMed ID: 18490838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic predictors of adrenocortical carcinoma: A single-center thirty-year experience.
    Pan LH; Yen CC; Huang CJ; Ng XN; Lin LY
    Front Endocrinol (Lausanne); 2023; 14():1134643. PubMed ID: 36967802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laparoscopic Versus Open Adrenalectomy for Localized/Locally Advanced Primary Adrenocortical Carcinoma (ENSAT I-III) in Adults: Is Margin-Free Resection the Key Surgical Factor that Dictates Outcome? A Review of the Literature.
    Mpaili E; Moris D; Tsilimigras DI; Oikonomou D; Pawlik TM; Schizas D; Papalampros A; Felekouras E; Dimitroulis D
    J Laparoendosc Adv Surg Tech A; 2018 Apr; 28(4):408-414. PubMed ID: 29319399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is the best approach to an apparently nonmetastatic adrenocortical carcinoma?
    Fassnacht M; Allolio B
    Clin Endocrinol (Oxf); 2010 Nov; 73(5):561-5. PubMed ID: 20738315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicitve Value of FDG Uptake in the Remaining Adrenal Gland Following Adrenalectomy for Adrenocortical Cancer.
    Loewe R; Rogowski-Lehmann N; Pfluger T; Reincke M; Hahner S; Bluemel C; Fassnacht M; Beuschlein F
    Horm Metab Res; 2021 Jan; 53(1):24-31. PubMed ID: 33086388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgery in adrenocortical carcinoma: Importance of national cooperation and centralized surgery.
    Hermsen IG; Kerkhofs TM; den Butter G; Kievit J; van Eijck CH; Nieveen van Dijkum EJ; Haak HR;
    Surgery; 2012 Jul; 152(1):50-6. PubMed ID: 22703895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant mitotane treatment for adrenocortical carcinoma.
    Terzolo M; Angeli A; Fassnacht M; Daffara F; Tauchmanova L; Conton PA; Rossetto R; Buci L; Sperone P; Grossrubatscher E; Reimondo G; Bollito E; Papotti M; Saeger W; Hahner S; Koschker AC; Arvat E; Ambrosi B; Loli P; Lombardi G; Mannelli M; Bruzzi P; Mantero F; Allolio B; Dogliotti L; Berruti A
    N Engl J Med; 2007 Jun; 356(23):2372-80. PubMed ID: 17554118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The management of postoperative disease recurrence in patients with adrenocortical carcinoma: a retrospective study in 106 patients.
    Calabrese A; Puglisi S; Borin C; Basile V; Perotti P; Pia A; Berchialla P; Volante M; Fiori C; Porpiglia F; Veltri A; Reimondo G; Terzolo M
    Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36655273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma.
    Fassnacht M; Hahner S; Polat B; Koschker AC; Kenn W; Flentje M; Allolio B
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4501-4. PubMed ID: 16895957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers.
    Fassnacht M; Johanssen S; Fenske W; Weismann D; Agha A; Beuschlein F; Führer D; Jurowich C; Quinkler M; Petersenn S; Spahn M; Hahner S; Allolio B;
    J Clin Endocrinol Metab; 2010 Nov; 95(11):4925-32. PubMed ID: 20668036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.